What Evofem Biosciences Inc's executives and directors are doing with their own shares, from SEC Form 3/4/5 filings — separating what the filings state (awards, withholding, disclosed plans) from what only the pattern of dates shows.
| 3 months | 12 months | |
|---|---|---|
| Open-market buys | 0 | 0 |
| Sells | 0 | 0 |
| Total trades | 0 | 0 |
| 3 months | 12 months | |
|---|---|---|
| Acquired | 0 | 0 |
| Disposed | 0 | 0 |
| Net activity | +0 | +0 |
View rich charts and dive into the patterns of specific insiders — who is accumulating, who is winding down, and which sale explanations the filings actually support.
| Insider | Relation | Date | Transaction | Shares | Price | Value | Shares held |
|---|---|---|---|---|---|---|---|
| Zhang Yan | CFO | Jan 12 | Open-market sale · S | −104 | $0.04 | −$4 | 0 |
| Kamdar Kim P. | Director | Dec 21 | Open-market sale · S | −10 | $0.62 | −$6.21 | 0 |
| Pelletier Saundra L | Chief Executive Officer | Dec 31 | Disposition to Issuer · D | −50,000 | — | — | 186,722 |
| File Justin J. | Chief Financial Officer | Dec 31 | Disposition to Issuer · D | −30,000 | — | — | 24,065 |
| Pelletier Saundra L | Chief Executive Officer | May 27 | Open-market buy · P | +141,000 | $0.35 | +$49.7K | 236,722 |
| Fitzpatrick Alexander A | General Counsel and Secretary | Feb 18 | Grant / award · A | +300,000 | — | — | 516,422 |
| Pelletier Saundra L | Chief Executive Officer | Feb 18 | Grant / award · A | +750,000 | — | — | 1,435,837 |
| File Justin J. | Chief Financial Officer | Feb 18 | Grant / award · A | +450,000 | — | — | 810,982 |
| Fitzpatrick Alexander A | General Counsel and Secretary | Dec 31 | Disposition to Issuer · D | −120,000 | — | — | 216,422 |
| Pelletier Saundra L | Chief Executive Officer | Dec 31 | Disposition to Issuer · D | −300,000 | — | — | 685,837 |
| File Justin J. | Chief Financial Officer | Dec 31 | Disposition to Issuer · D | −120,000 | — | — | 360,982 |
| Fitzpatrick Alexander A | General Counsel and Secretary | Dec 20 | Open-market buy · P | +25,000 | $0.39 | +$9.73K | 336,422 |
| Pelletier Saundra L | Chief Executive Officer | Dec 20 | Open-market buy · P | +135,000 | $0.38 | +$50.6K | 985,837 |
| File Justin J. | Chief Financial Officer | Dec 20 | Open-market buy · P | +40,594 | $0.37 | +$15K | 480,982 |
| Barrans Russell | Chief Commercial Officer | Jul 08 | Withheld — tax / exercise cost · F | −19,998 | $0.98 | −$19.5K | 448,554 |
| Kamdar Kim P. | Director | Jun 18 | Open-market buy · P | +10,000 | $1.17 | +$11.7K | 19,287 |
| O'Brien Anthony Stephen | Director | Jun 14 | Open-market buy · P | +8,140 | $1.31 | +$10.7K | 8,140 |
| Barrans Russell | Chief Commercial Officer | Jun 11 | Open-market buy · P | +18,180 | $1.14 | +$20.7K | 468,552 |
| Rarick Lisa Dale | Director | Jun 11 | Open-market buy · P | +5,000 | $1.20 | +$5.99K | 10,250 |
| Fitzpatrick Alexander A | General Counsel and Secretary | Jun 10 | Open-market buy · P | +10,000 | $1.03 | +$10.3K | 311,422 |
Loading...
